WebApr 3, 2024 · Determine whether Cingulate Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Cingulate Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and … WebCingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products.
CING Stock Price Cingulate Inc. Stock Quote (U.S.: Nasdaq ...
WebOct 26, 2024 · Cingulate Therapeutics, LLC is a privately-held, clinical-stage, biopharmaceutical company focused on the development of new and innovative products … WebMar 10, 2024 · Cingulate plans to commence two CTx-1301 Phase 3 clinical studies in 2024: (1) a fixed-dose pediatric and adolescent safety and efficacy study, which will … how is penicillin removed from the blood
Shane J. Schaffer - Biography - MarketScreener.com
WebShane J. Schaffer founded Cingulate, Inc., Cingulate Works, Inc. and Cingulate Therapeutics LLC. Presently, Dr. Schaffer holds the position of Chairman & Chief Executive Officer for Cingulate, Inc. and Chairman & Chief Executive Officer of Cingulate Therapeutics LLC and Chairman & Chief Executive Officer of Cingulate Works, Inc. … WebCingulate Inc. 1901 W 47th Place Kansas City, KS 66205 (913) 942-2300 [email protected]. Legal 6 South Street, Suite 203 Morristown, New Jersey 07960. Clinical Trial Investigators [email protected]. Investor Relations Thomas Dalton Head of Investor & Public Relations (913) 942-2301 WebSep 23, 2024 · EX-10.7 6 ex10-7.htm . Exhibit 10.7 . EMPLOYMENT AGREEMENT . This AGREEMENT (this “Agreement”) is made and effective as of this 23rd day of September, 2024 by and between CINGULATE THERAPEUTICS LLC, a Delaware Limited Liability Company, whose principal address is 1901 W. 47 th Place, 3 rd Floor, Kansas City, KS … how is penicillin administered